RBCL (RBC Life Sciences) Cyclically Adjusted Revenue per Share: $0.00 (As of Jun. 2017)


What is RBC Life Sciences Cyclically Adjusted Revenue per Share?

RBC Life Sciences RBCL +0.14% Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2017.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

RBC Life Sciences's adjusted revenue per share for the three months ended in Jun. 2017 was $2.593. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $0.00 for the trailing ten years ended in Jun. 2017.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-11), RBC Life Sciences's current stock price is $0.0007. RBC Life Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2017 was $0.00. RBC Life Sciences's Cyclically Adjusted PS Ratio of today is .


RBC Life Sciences  (OTCPK:RBCL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


RBC Life Sciences Cyclically Adjusted Revenue per Share Related Terms


RBC Life Sciences Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Cyclically Adjusted Revenue per Share Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

RBCL vs SKVI, TISUQ, TECR: Cyclically Adjusted Revenue per Share Comparison

For the Household & Personal Products subindustry, RBC Life Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Life Sciences Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, RBC Life Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where RBC Life Sciences's Cyclically Adjusted PS Ratio falls into.



RBC Life Sciences Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, RBC Life Sciences's adjusted Revenue per Share data for the three months ended in Jun. 2017 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2017 (Change)*Current CPI (Jun. 2017)
=2.593/244.9550*244.9550
=2.593

Current CPI (Jun. 2017) = 244.9550.

RBC Life Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200709 3.446 208.490 4.049
200712 3.085 210.036 3.598
200803 2.813 213.528 3.227
200806 3.002 218.815 3.361
200809 4.332 218.783 4.850
200812 3.209 210.228 3.739
200903 2.745 212.709 3.161
200906 3.007 215.693 3.415
200909 2.959 215.969 3.356
200912 2.583 215.949 2.930
201003 3.135 217.631 3.529
201006 3.501 217.965 3.935
201009 2.726 218.439 3.057
201012 3.194 219.179 3.570
201103 2.901 223.467 3.180
201106 3.323 225.722 3.606
201109 3.176 226.889 3.429
201112 3.309 225.672 3.592
201203 2.730 229.392 2.915
201206 2.941 229.478 3.139
201209 3.020 231.407 3.197
201212 2.623 229.601 2.798
201303 2.560 232.773 2.694
201306 3.011 233.504 3.159
201309 2.995 234.149 3.133
201312 2.914 233.049 3.063
201403 2.583 236.293 2.678
201406 3.565 238.343 3.664
201409 3.397 238.031 3.496
201412 3.236 234.812 3.376
201503 2.423 236.119 2.514
201506 2.799 238.638 2.873
201509 2.444 237.945 2.516
201512 3.347 236.525 3.466
201603 2.348 238.132 2.415
201606 2.707 241.018 2.751
201609 3.311 241.428 3.359
201612 3.279 241.432 3.327
201703 2.577 243.801 2.589
201706 2.593 244.955 2.593

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $0.00 mean?
RBC Life Sciences (RBCL) has a Cyclically Adjusted Revenue per Share of $0.00 as of Jun. 2017. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on RBC Life Sciences and its competitors.
Is RBC Life Sciences' Cyclically Adjusted Revenue per Share too high?
RBC Life Sciences' current Cyclically Adjusted Revenue per Share is $0.00.
How does RBC Life Sciences' Cyclically Adjusted Revenue per Share compare to SKVI and TISUQ?
RBC Life Sciences' Cyclically Adjusted Revenue per Share of $0.00 can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Consumer Packaged Goods company?
A good Cyclically Adjusted Revenue per Share depends on the Consumer Packaged Goods industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on RBC Life Sciences and its competitors. RBC Life Sciences's current Cyclically Adjusted Revenue per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Cyclically Adjusted Revenue per Share of $0.00. The current Cyclically Adjusted Revenue per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Cyclically Adjusted Revenue per Share is $0.00 as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.